Diego Cadavid
Diego Cadavid
Fulcrum Therapeutics
Verified email at fulcrumtx.com - Homepage
TitleCited byYear
Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis
YC Learmonth, RW Motl, BM Sandroff, JH Pula, D Cadavid
BMC neurology 13 (1), 37, 2013
2362013
Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study
D Cadavid, LJ Wolansky, J Skurnick, J Lincoln, J Cheriyan, ...
Neurology 72 (23), 1976-1983, 2009
1972009
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
P Vermersch, L Kappos, R Gold, JF Foley, T Olsson, D Cadavid, C Bozic, ...
Neurology 76 (20), 1697-1704, 2011
1852011
Magnetic resonance imaging pattern in natalizumab‐associated progressive multifocal leukoencephalopathy
TA Yousry, D Pelletier, D Cadavid, A Gass, ND Richert, EW Radue, ...
Annals of neurology 72 (5), 779-787, 2012
1622012
Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals
D Cadavid, AG Barbour
Clinical infectious diseases 26 (1), 151-164, 1998
1491998
Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies
D Cadavid, H Mena, K Koeller, RA Frommelt
Journal of Neuropathology & Experimental Neurology 59 (9), 768-773, 2000
1432000
Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis.
D Cadavid, DD Thomas, R Crawley, AG Barbour
Journal of Experimental Medicine 179 (2), 631-642, 1994
1371994
Localization of Borrelia Burgdorferi in the Nervous System and Other Organs in a Nonhuman Primate Model of Lyme Disease
D Cadavid, T O'Neill, H Schaefer, AR Pachner
Laboratory investigation 80 (7), 1043, 2000
1292000
Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic
S Mi, RB Pepinsky, D Cadavid
CNS drugs 27 (7), 493-503, 2013
1262013
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
JQ Tran, J Rana, F Barkhof, I Melamed, H Gevorkyan, MP Wattjes, ...
Neurology-Neuroimmunology Neuroinflammation 1 (2), e18, 2014
1122014
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
D Cadavid, L Balcer, S Galetta, O Aktas, T Ziemssen, L Vanopdenbosch, ...
The Lancet Neurology 16 (3), 189-199, 2017
1102017
The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis
K Narayan, D Dail, L Li, D Cadavid, S Amrute, P Fitzgerald‐Bocarsly, ...
Annals of Neurology: Official Journal of the American Neurological …, 2005
942005
Human cerebral infarct: a proposed histopathologic classification based on 137 cases
H Mena, D Cadavid, EJ Rushing
Acta neuropathologica 108 (6), 524-530, 2004
932004
Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae.
D Cadavid, PM Pennington, TA Kerentseva, S Bergström, AG Barbour
Infection and immunity 65 (8), 3352-3360, 1997
861997
Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world
MD Goldman, RW Motl, J Scagnelli, JH Pula, JJ Sosnoff, D Cadavid
Neurology 81 (21), 1856-1863, 2013
802013
The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy
MP Wattjes, ND Richert, J Killestein, M de Vos, E Sanchez, ...
Multiple Sclerosis Journal 19 (14), 1826-1840, 2013
772013
Cardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferi
D Cadavid, Y Bai, E Hodzic, K Narayan, SW Barthold, AR Pachner
Laboratory investigation 84 (11), 1439, 2004
742004
Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials
RHB Benedict, A Smerbeck, R Parikh, J Rodgers, D Cadavid, D Erlanger
Multiple Sclerosis Journal 18 (9), 1320-1325, 2012
732012
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS
SE Bushnell, Z Zhao, CC Stebbins, D Cadavid, AM Buko, ET Whalley, ...
Neurology 79 (6), 531-537, 2012
672012
Acute optic neuritis: unmet clinical needs and model for new therapies
SL Galetta, P Villoslada, N Levin, K Shindler, H Ishikawa, E Parr, ...
Neurology-Neuroimmunology Neuroinflammation 2 (4), e135, 2015
612015
The system can't perform the operation now. Try again later.
Articles 1–20